• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    Dr. Ayoade Alakija: 'ACT-A is not winding down'

    Dr. Ayoade Alakija believes ACT-A was the best possible mechanism that was created at a time of crisis — but one that is not without its flaws in communication and execution. The goal to reach equitable access has not been met, she admits.

    By Amruta Byatnal // 22 September 2022
    WHO Special Envoy for the Access to COVID-19 Tools Accelerator, Dr. Ayoade Alakija. Screengrab from: UNAIDS via Youtube

    More than nine months after she took over the role of WHO Special Envoy for the Access to COVID-19 Tools Accelerator, Dr. Ayoade Alakija believes the goal of the coordinating body has not been achieved yet.

    “Our goal was to reach equitable access, we haven't reached it yet,” she told Devex in an interview last week. Clearing the air about ACT-A’s future, she said it is not winding down. “Nothing is ending because the pandemic has evolved and the virus is evolving.”

    Alakija was also candid about the limitations of the body. She believes it was the best possible mechanism that was created at a time of crisis — but one that is not without its flaws in communication and execution.

    Alakija, a Nigeria-born medical doctor with a master's degree in Public Health and Epidemiology from The London School of Hygiene and Tropical Medicine, is also one of the fiercest critics of racism in global health. In July, as several AIDS activists from the global south were denied visas to enter Montreal for AIDS2022, Alakija tweeted in protest, stating that she will not be attending the conference in person.

     “What would have happened if we didn't have the accelerator? It was flawed in its execution. But we got the products. But we failed on equitable access.”

    — Dr. Ayoade Alakija, WHO Special Envoy for the Access to COVID-19 Tools Accelerator

    Asked what role she sees for herself in dismantling power structures, she said, “I think my role is just to show up every day … to hold up a mirror to those who are perpetuating racism and help them to see what they're doing and help them to see the hurt.”

    This conversation has been edited for length and clarity.

    What is the current status of ACT-A, is it going to continue in its current form or will it be winding down?

    ACT-A is not winding down. I think that there's been a lot of confusion and one of the weaknesses of ACT-A has been the messaging and the communication … which is understandable because it was all set up so quickly in the middle of a crisis. But it is not winding down. The facilitation council [representatives of civil society and communities] is ending the regular scheduled meetings [but] they will still convene as needed.

    You know, I chair a meeting every Thursday of the [ACT] accelerator with the top guys in global health, with the head of Global Fund Peter Sands, with [World Health Organization chief] Tedros, Seth Berkley of CEPI, and that is not changing.

    Nothing is ending because the pandemic has evolved and the virus is evolving. Our goal was to reach equitable access, we haven't reached it yet … not just the vaccines, but all countermeasures. We haven’t reached it. I mean, there's vaccines available, but are they fully accessible?

    Some countries have a next generation vaccine, the bi-valent vaccine. The U.S. has their BA.5 vaccine [to protect against omicron], but other countries in the world are still trying to get the first and second doses out to high risk people. That is not equity.

    And COVAX has assured funding until 2023, is that right?

    Everyone who talks to me about ACT-A talks about COVAX. I mean, COVAX is the vaccine pillar of ACT-Accelerator, there is also a diagnostics pillar and the therapeutics pillar and a health systems connector. All of those have been supported through until 2023. But I mean, if there is need for greater funding in the future, I imagine the world is not going to stop and say, “well, we're not going to fund what is needed going forward.”

    It's been an emergency response to a global threat, which came unexpectedly and so we have to … remain flexible and agile and nimble in how we address it. And so that I think too, too much of the world is thinking of both ACT-A and the various pillars as development structures. One of my theses from the word go is that we haven't had enough of a humanitarian mindset towards this crisis. You know, those who are humanitarians will not imagine that anyone says the ACT-A is coming to an end because — end of what?

    As flawed as it was, it is the only mechanism that exists that was end-to-end. … What you need to do is look at the counterfactual, what would have happened if we didn't have the accelerator? It was flawed in its execution. But we got the products. But we failed on equitable access.

    Are you satisfied with the amount of funding ACT-A has received so far?

    I think that there has been funding provided, but … we need to see more of a spend. There's still money left over that hasn't been rolled out. Some of the World Bank money at the very beginning was very slow to roll out. We're now beginning to see that come out.

    Part of this comes [down] to the top-down nature, there has been very little commitment to funding communities, to funding grassroots work for delivery. … A lot of it was very top-heavy. We invested a lot of money in the purchase and the product delivery side … so there was a lot of money invested back into high-income countries, back into the pharma industry, back into those places of the product development and purchase side. But when it comes to equitable access, when [it comes to] the delivery side, funding needs to go into strengthening of health systems, [it] needs to go into community mobilization, community … support, and funding health care workers, health workforce, all of that. We have seen too little of that. And we still continue, to my mind, to see too little of that and it comes from a place where there's a lack of trust. There's a lack of trust in funding local regional initiatives.

    You’ve been outspoken about racism in global health and the harm that is caused by the colonial attitude of global north institutions. What do you see as your role in dismantling these ingrained power structures and your impact in these rooms?

    I think my role is just to show up every day, to push back — either the cost or the perceived cost — to hold up a mirror to those who are perpetuating racism and help them to see what they're doing and help them to see the hurt. Not just that we’re angry? No, it's hurt. It's a deep, deep sense of hurt that it causes and how that affects the world.

    I have found allies within ACT-A, and, you know, a lot of the people that I have met, just in that space, they understand us more because more of us are in the room. There’s the scope for change, we need more of us at the table.

    Read more:

    ► ACT-A launches new plan amid persistent challenges

    ► 'Goodwill is not enough' to achieve vaccine equity, experts say

    ► A review says ACT-A should continue. Experts say changes are needed.

    • Global Health
    • Institutional Development
    • Private Sector
    • The Access to COVID-19 Tools (ACT) Accelerator
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Amruta Byatnal

      Amruta Byatnalamrutabyatnal

      Amruta Byatnal is a Senior Editor at Devex where she edits coverage on global development, humanitarian crises and international aid. She writes Devex CheckUp, a weekly newsletter on the latest developments in global health. Previously, she worked for News Deeply in the United States, and The Hindu in India. She is a graduate of Cornell University where she studied international development. She is currently based in New Delhi.

    Search for articles

    Related Stories

    Global healthGavi’s Sania Nishtar is ‘very hopeful’ US will return as a donor

    Gavi’s Sania Nishtar is ‘very hopeful’ US will return as a donor

    The future of US aidHow Samantha Power performed a delicate balancing act as USAID chief

    How Samantha Power performed a delicate balancing act as USAID chief

    78th World Health AssemblyThai official calls for WHO to be reborn as ‘small, lean’ institute

    Thai official calls for WHO to be reborn as ‘small, lean’ institute

    Accelerating ActionThe potential of city-level financing for NCDs

    The potential of city-level financing for NCDs

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      How AI-powered citizen science can be a catalyst for the SDGs
    • 5
      WHO names new directors in ongoing restructure
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement
    We use cookies to help improve your user experience. By using our site, you agree to the terms of our Privacy Policy.